$430.36
-1.34-0.31%
Last update: Oct 30, 5:52 PM
Madrigal Pharmaceuticals Inc (MDGL) Stock Price, Quote, News & History
MDGLNASDAQ
Paulson's hedge fund reduced its equity book to $2.58B in Q2, exiting two positions and opening a stake in Alphabet.
You can purchase shares of Madrigal Pharmaceuticals (NASDAQ:MDGL) through any online brokerage.
Other companies in Madrigal Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Madrigal Pharmaceuticals has a consensus price target of $625.29.
The stock price for Madrigal Pharmaceuticals (NASDAQ: MDGL) is $433.06 last updated October 30, 2026 at 5:52 PM EDT.
There are no upcoming dividends for Madrigal Pharmaceuticals.
Madrigal Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Madrigal Pharmaceuticals.
Madrigal Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver...
